GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.365 +0.085 (+2.59%)

Delayed Quote Updated: 3:20 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 18, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 18, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 17, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

What 16 Analyst Ratings Have To Say About GoodRx Holdings ↗

May 10, 2022

Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter:

Via Benzinga

GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers

May 17, 2022

From GoodRx

Via Business Wire

GOODRX ALERT: Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Inc. on Behalf of GoodRx Stockholders and Encourages Investors to Contact the Firm

May 12, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors

May 12, 2022

From Kirby McInerney LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 11, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 11, 2022

From Smith Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

May 11, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Peak Or Persist? Investors Parse April's Hotter-than-Expected 8.3% Inflation Jump ↗

May 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here's What You Need To Know ↗

May 11, 2022

Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 10, 2022

Via Benzinga

Why Is Desktop Metal (DM) Stock Plunging 40% Today? ↗

May 10, 2022

Desktop Metal (DM) stock is falling hard on Tuesday following the release of the 3D printing company's earnings report for Q1 2022.

Via InvestorPlace

103 Biggest Movers From Yesterday ↗

May 11, 2022

Gainers

Via Benzinga

77 Stocks Moving In Tuesday's Mid-Day Session ↗

May 10, 2022

Gainers

Via Benzinga

PLTR Stock Falls Another 5% as RBC Downgrades Palantir ↗

May 10, 2022

Palantir Technologies (PLTR) stock is slipping on Tuesday as investors react to a downgrade for the shares from RBC Capital Markets.

Via InvestorPlace

Why Is GoodRx (GDRX) Stock Down Today? ↗

May 10, 2022

GoodRx (GDRX) stock is slipping on Tuesday despite the healthcare company beating out estimates for the first quarter of 2022.

Via InvestorPlace

GoodRx Shares Tumble As FY22 Guidance Hit By Grocery Chain Prescription Dispute ↗

May 10, 2022

GoodRx Holdings Inc (NASDAQ: GDRX) shares fell after it expects FY22 revenue to take a hit due to recent actions by one grocery store chain that represents a sizable chunk of its grocery prescription...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022 ↗

May 10, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 10, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 10, 2022

Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

30 Stocks Moving in Tuesday's Pre-Market Session ↗

May 10, 2022

Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.

Via Benzinga

GoodRx Holdings: Q1 Earnings Insights ↗

May 09, 2022

GoodRx Holdings (NASDAQ:GDRX) reported its Q1 earnings results on Monday, May 9, 2022 at 04:07 PM. Here's what investors need to know about the announcement. Earnings GoodRx Holdings beat estimated...

Via Benzinga

GoodRx Releases First Quarter 2022 Financial Results

May 09, 2022

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx to Present at the RBC Capital Markets 2022 Global Healthcare Conference

May 02, 2022

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Teams Up with AssistRx to Increase Provider Awareness of Simplified Specialty Medication and Treatment Initiation

May 02, 2022

From GoodRx

Via Business Wire

GoodRx Closes Acquisition of vitaCare, A Tech-Enabled Pharmacy Services Platform

April 14, 2022

From GoodRx

Via Business Wire

Where GoodRx Holdings Stands With Analysts ↗

April 11, 2022

Over the past 3 months, 13 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022 ↗

April 11, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.